Valproic acid Recruiting Phase 3 Trials for Spinal Muscular Atrophy (SMA) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01671384Valproate and Levocarnitine in Children With Spinal Muscular Atrophy